Breakthrough FDA-cleared device combines the power of ECG, digital auscultation, and mobile app integration with any existing stethoscope
Rijuven has launched CardioSleeve for paediatrics, the first FDA-cleared device. The device adds ECG capabilities to transform any existing stethoscope into a smart, mobile-connected device, complete with 3-Lead ECG, digital auscultation, and real-time digital analysis optimised for paediatric care. With CardioSleeve, paediatricians and clinicians can quickly and accurately visualise heart sound, analyse for arrhythmia or murmur, and identify heart failure.
CardioSleeve murmur detection analysis aids in the diagnosis of pathological and physiological heart sounds in patients as young as infants, at heart rates up to 180 beats per minute. Paediatricians and clinicians can simply attach the CardioSleeve to an existing stethoscope, where it acquires the digital acoustic and electric footprints of the heart and transmits them to a mobile device for real-time analysis. This allows for the creation of the systolic performance index, a measure of ejection fraction, critical to identifying heart failure.
CardioSleeve for paediatrics is part of the Rijuven i2Dtx platform. i2Dtx is a comprehensive, portable, cloud-based medical device platform for heart, lung, vital signs, imaging and lab clinical assessments for any physical examination. The i2DTX platform includes a CardioSleeve and connected devices including an otoscope, pulse ox, IR thermometer and blood pressure cuff. Optional additions include a weight scale, spirometer, ultrasound, and blood glucose monitor. All devices can be wirelessly deployed to assess patients at any point of care. i2Dtx connects vitals, diagnostic, and lab devices with live notes, real-time consults, HD photos for visual exams and a complete EMR report both in the facility and remotely.